By focusing on genes downregulated by BCR-ABL or in CML patients compared to mock-transduced cells or healthy controls, we found three common genes: DNTT, IRF8, and FLT3 (Fig. 3a). The gene discussed is FLT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.